XTLB

XTL BIOPHARMACEUTICALS LTD

NASDAQ · Biotechnology mkt cap 6,069,933
Company page ›Healthcare ›Biotechnology
High confidence Medium Low Unknown
Line thickness = strength · colour = confidence

Drawing the 24 strongest — 15 further edges are not on this diagram

Relationships 24 of 39

Capped at 24 strongest — 15 not shown

Co-mentioned in news 4

Both companies were named in the same news article. Co-mention is adjacency, not a business relationship.

DRS Leonardo DRS, Inc. Graph ›
0.00 conf n/a
FGL Founder Group Ltd Graph ›
0.00 conf n/a
PH Parker-Hannifin Corp Graph ›
0.00 conf n/a
THH TryHard Holdings Ltd Graph ›
0.00 conf n/a
Peer similarity 20

Computed by us from market capitalisation, earnings cadence, dividend frequency and exchange. Not a reported relationship.

ACXP Acurx Pharmaceuticals, Inc. Graph ›
1.00 conf 1.00
PCSA Processa Pharmaceuticals, Inc. Graph ›
1.00 conf 1.00
LIMN Liminatus Pharma, Inc. Graph ›
1.00 conf 1.00
PULM Pulmatrix, Inc. Graph ›
0.99 conf 1.00
CVKD Cadrenal Therapeutics, Inc. Graph ›
0.99 conf 1.00
ADTX Aditxt, Inc. Graph ›
0.99 conf 1.00
BRTX BioRestorative Therapies, Inc. Graph ›
0.99 conf 1.00
SNGX SOLIGENIX, INC. Graph ›
0.98 conf 1.00
EVGN Evogene Ltd. Graph ›
0.97 conf 1.00
TCRT Alaunos Therapeutics, Inc. Graph ›
0.97 conf 1.00
MBIO MUSTANG BIO, INC. Graph ›
0.97 conf 1.00
VIVS VivoSim Labs, INC. Graph ›
0.97 conf 1.00
VTGN Vistagen Therapeutics, Inc. Graph ›
0.95 conf 1.00
CALC CalciMedica, Inc. Graph ›
0.95 conf 1.00
PPBT PURPLE BIOTECH LTD. Graph ›
0.94 conf 1.00
RNAZ Transcode Therapeutics, Inc. Graph ›
0.93 conf 1.00
CTXR Citius Pharmaceuticals, Inc. Graph ›
0.92 conf 1.00
QNCX Quince Therapeutics, Inc. Graph ›
0.87 conf 1.00
APM Aptorum Group Ltd Graph ›
0.82 conf 1.00
TOVX Theriva Biologics, Inc. Graph ›
0.75 conf 1.00

Edge strength is relative to the strongest edge in this view and is not comparable across views. Confidence is the mean confidence of the active evidence behind an edge, on an absolute scale. Peer-similarity edges are computed by us and are not a reported relationship; co-mention edges record that two companies appeared in the same article, which is adjacency rather than a business connection.